z-logo
Premium
Disparate ligand‐mediated Ca 2+ responses by wild‐type, mutant Ser 200 Ala and Ser 204 Ala α 2A ‐adrenoceptor : G α15 fusion proteins: evidence for multiple ligand‐activation binding sites
Author(s) -
Pauwels P J,
Colpaert F C
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703455
Subject(s) - mutant , ligand (biochemistry) , fusion , chemistry , physics , crystallography , receptor , biochemistry , gene , linguistics , philosophy
Ligand : receptor interactions were analysed at wt, mutant Ser 200 Ala and Ser 204 Ala α 2A ARs by measuring Ca 2+ responses in CHO‐K1 cells either by co‐expression with a G α15 protein or at a receptor : G α15 protein stoichiometry of 1.0 using fusion proteins. The magnitude of the UK 14304‐mediated Ca 2+ response as elicited by a G α15 protein was largest with both mutant Ser 200 Ala and Ser 204 Ala α 2A ARs compared to the wt α 2A AR in the co‐expression and fusion protein experiments. The activation profiles of the wt and both mutant α 2A ARs as analysed by a series of α 2 AR agonists differed. d‐Medetomidine and clonidine appeared most efficacious at the Ser 204 Ala α 2A AR, whereas oxymetazoline was also partially active at the Ser 200 Ala α 2A AR. Talipexole was silent at both mutant α 2A ARs. The intrinsic activity of (−)‐adrenaline was either absent or partial at the Ser 204 Ala and Ser 200 Ala α 2A AR, respectively. This latter observation is related to its lower binding affinity for both mutant α 2A ARs. Ligands characterized as antagonists at wt and Ser 200 Ala α 2A ARs demonstrated either no intrinsic activity (i.e., RX 811059) or positive efficacy with a different rank order of maximal response at the Ser 204 Ala α 2A AR (atipamezole=SKF 86466=idazoxan>dexefaroxan) than Asp 79 Asn α 2A AR (atipamezole>idazoxan≃SKF 86466>dexefaroxan) and Thr 373 Lys α 2A AR (SKF 86466>atipamezole≃idazoxan>dexefaroxan). These effects were only observed in the co‐expression experiments at concentrations in line with their binding affinities. In conclusion, these Ca 2+ data suggest that multiple activation binding sites exist for these ligands at the α 2A AR, and that their activation may be affected in different ways by the mutations being investigated.British Journal of Pharmacology (2000) 130 , 1505–1512; doi: 10.1038/sj.bjp.0703455

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom